Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - Vanda Pharmaceuticals Inc. | w79415exv31w1.htm |
EX-31.2 - EX-31.2 - Vanda Pharmaceuticals Inc. | w79415exv31w2.htm |
10-Q - 10-Q - Vanda Pharmaceuticals Inc. | w79415e10vq.htm |
EXHIBIT 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section
1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Vanda
Pharmaceuticals Inc., (the Company), does hereby certify, to the best of such officers
knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 (the Form 10-Q) of the
Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material
respects, the consolidated financial condition and results of operations of the Company.
Date: August 6, 2010 |
/s/ Mihael H. Polymeropoulos | |
Mihael H. Polymeropoulos | ||
Chairman and Chief Executive Officer | ||
(Principal Executive Officer) |
Date: August 6, 2010 |
/s/ Stephanie R. Irish | |
Stephanie R. Irish | ||
Acting Chief Financial Officer | ||
(Principal Financial and Accounting Officer) |
A signed original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission (SEC) or its staff upon request. This certification accompanies the Form 10-Q to which
it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any
filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act
of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any
general incorporation language contained in such filing.